- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01971723
Multi-ingredient Supplement for Strength and Power
The Impact of T+ Supplementation on Anabolic Hormone Profile and Performance in Power Athletes
It has been suggested that high amounts of total serum testosterone levels correlate with higher lean body mass, lowered fat mass, greater muscle strength, and faster recovery. These suggestions drive athletes and body builders to find ways to raise their testosterone levels. Many athletes and bodybuilders look to alternative methods to anabolic steroids in order increase their testosterone levels without legal repercussions or physiological side effects. Herbs and other plant extracts have been introduced as a possible source to naturally boost testosterone levels. Research supporting the use of herbs and plant extracts has been shown to be equivocal. However, evidence in studies with hypogonadal men suggests that longjack root may naturally boost testosterone levels.
Onnit Labs, LLC has packaged this supplement (T+) which claims it can naturally boost testosterone and lower estrogen levels and subsequently improve performance. This product is a powder (11g) that is mixed with 16 oz of water and consumed 20 minutes prior to anaerobic workouts, such as high intensity weight training.
T+ is a multi-ingredient supplement that consists of vitamins B5 and B6, magnesium aspartic acid, mucuna pruriens, longjack root, nettle root, red clover luteolin, resveratrol, beta- alanine, branch chain amino acids, L- glutamine, Bioperine, and Fibersol 2.
The active ingredients purported to boost plasma testosterone levels are mucuna pruriens, longjack root, and magnesium aspartic acid. The active ingredients claimed to lower plasma estrogen concentrations are red clover, luteolin, resveratrol and nettle root. All other ingredients (Branch Chain Amino Acids and Beta-Alanine) have been documented to improve exercise performance.
It is hypothesized that there will not be any physiological changes after supplementation of T+. It is also hypothesized that performance will not be affected by the supplementation of T+.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Florida State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must be familiar with the three main powerlifting movements (squat, bench and deadlift)
- Must have one month training with a designated strength coach to understand the expectations of the strength coach and movement patterns for performance
- Have no pre-existing musculoskeletal disorders
- Participate in the three-week supplement wash out prior to beginning the experiment (except for basic protein supplements and multivitamins)
Exclusion Criteria:
- Female
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: T+ Supplement
This arm requires the participants to take a prescribed dose of the T+ supplement for 4 weeks while completing an exercise regiment.
|
Randomized, placebo-controlled, double blind protocol with two treatment groups (matched by lean body mass).
Group 1 will receive the recommended serving of one scoop (11g) of T+ supplement.
This serving will be taken 45 minutes before the beginning of working out on an empty stomach (>1 hour after meal).
On non-training days, the participants will also take a serving at the same time as on training days.
This will continue for four weeks (28 days).
|
Placebo Comparator: Placebo
This arm requires the participants to take a prescribed dose of a calorie matched placebo for 4 weeks while completing an exercise regiment.
|
The placebo group will consume a calorie-match placebo in the same manner as the supplement group (one serving 45 minutes prior to work outs on an empty stomach).
The placebo group will also follow the same supplementation patterns and workout as their counterparts in the supplement group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Strength Performance Outcomes
Time Frame: Baseline measures and 4 weeks from start of study
|
Measurement of one repetition maximums strength for all competition lifts included in a standard, ungeared, powerlifting competition (squat, bench, and deadlift). This testing will take place before the supplementation of either T+ or placebo and at the end of the four-week training period. Each measure was only compared within it's own category against the baseline measurement and against that of the other group at the same time point. |
Baseline measures and 4 weeks from start of study
|
Insulin Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements of insulin will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Blood Lipid Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for blood lipid panels will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Total Testosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Estrogen Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for estrogen will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Insulin-like Growth Factor-I Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for insulin-like growth factor-I will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Bio-availableTestosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for total testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Free Testosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for free testosterone will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Dihydrotestosterone Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Measurements for dihydrotestosterone (DHT) will occur on three occasions: prior to the start of supplementation and training, at the end of two weeks, and finally at the end of training.
|
Baseline, 2-week mark, 4-week mark
|
Cortisol Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Baseline, 2-week mark, 4-week mark
|
|
Sex-hormone Binding Globulin Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Baseline, 2-week mark, 4-week mark
|
|
Creatine-Kinase Outcomes
Time Frame: Baseline, 2-week mark, 4-week mark
|
Baseline, 2-week mark, 4-week mark
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Volume Performance Outcomes
Time Frame: 4 Weeks
|
During the four weeks, the volume ((weight x reps)set 1+(weight x reps)set 2+ (weight x reps)set 3….. ) will be calculated and measured for each exercise in each lifting session.
|
4 Weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael J Ormsbee, PhD, Florida State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HSC#: 2013.10364
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supplement
-
University of British ColumbiaCompletedDietary Supplement: Ketone Supplement | Dietary Supplement: PlaceboCanada
-
Société des Produits Nestlé (SPN)Completed
-
Universidad Católica San Antonio de MurciaCompleted
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedMedication and Supplement Use During Pregnancy
-
Universidad Francisco de VitoriaUniversidad de Granada; Universidad Rey Juan Carlos; Camilo Jose Cela UniversityCompleted
-
Medical University of WarsawUnknown
-
University of North Carolina, Chapel HillEnvironmental Protection Agency (EPA)CompletedHealthy | Dietary SupplementUnited States
-
The First Affiliated Hospital with Nanjing Medical...Baxter Healthcare CorporationUnknownNutritional Supplement ToxicityChina
-
Universität des SaarlandesCompletedNutritional Supplement ToxicityGermany
-
University of California, DavisActive, not recruitingEffect of Food SupplementUnited States
Clinical Trials on T+ Supplement
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Universidade Federal do AmazonasCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Hospital Universitario... and other collaboratorsCompletedOverweight | HypercholesterolemiaBrazil
-
Probi ABCompleted
-
Chair for Biomarkers of Chronic DiseasesKing AbdulAziz City for Science and TechnologyRecruitingObesity | Metabolic DiseaseSaudi Arabia
-
Griffin HospitalISOThrive Inc.Completed
-
Wageningen UniversityCompletedInflammation | Glucose Tolerance | Lipid Homeostasis | Vascular FunctionNetherlands
-
Maastricht University Medical CenterNutricia ResearchRecruitingPulmonary Disease, Chronic ObstructiveNetherlands
-
NorthShore University HealthSystemAnn & Robert H Lurie Children's Hospital of Chicago; Northwestern University... and other collaboratorsCompletedPremature, Extremely Low Birth Weight Infants | Polyunsaturated Fatty Acid LevelsUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteNot yet recruiting